Clinical benefit of continuing crizotinib therapy after initial disease progression in Chinese patients with advanced ALK-rearranged non-small-cell lung cancer

Por Hong, Xiangchan, Chen, Qi, Ding, Lingyu, Liang, Ying, Zhou, Ningning, Fang, Wenfeng, Chen, Xinru, Wu, Haiying
Publicado no Oncotarget (2017)

Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement: Frequency, Clinical-Pathologic Characteristics, and Response to ALK Inhibitor()

Por Chen, Xinru, Zhang, Yu, Lu, Jiabin, Xu, Chunwei, Liang, Jianzhong, Wang, Fang, Sun, Wenyong, Fang, Sangao, Yuan, Jingping, Wang, Huijuan, Wang, Hui, Liu, Xuewen, Chen, Likun
Publicado no Transl Oncol (2017)

Long non-coding RNA ATB promotes malignancy of esophageal squamous cell carcinoma by regulating miR-200b/Kindlin-2 axis

Por Li, Zhongwen, Wu, Xiaoliang, Gu, Ling, Shen, Qi, Luo, Wen, Deng, Chuangzhong, Zhou, Qianghua, Chen, Xinru, Li, Yanjie, Lim, ZuanFu, Wang, Xing, Wang, Jiahong, Yang, Xianzi
Publicado no Cell Death Dis (2017)